• Home
  • About Us
  • Solutions
    • Industries
      • Phamaceuticals
      • BioTech
      • AgTech
      • Cannabis
      • CBD-Hemp
      • Technology
    • Advisory
      • Turn Around & Transformation
      • Board Member Recruitment
      • PPMs, CIMs, Executive Summaries and Pitch Decks
      • Financial Modeling and Capital Planning
      • Product Commercialization
  • Access to Capital
    • Debt Funding
      • MTN
    • M&A
  • Canna-Hemp Debt Fund
    • Cannabis Capital Markets
    • The Fund
  • Insights
    • Blog33
    • The Edge Newsletters
    • News & Events
    • Tracking Smart Money
Let’s Talk
highwaylogoheader-1
  • Home
  • About Us
  • Solutions
    • Industries
      • Phamaceuticals
      • BioTech
      • AgTech
      • Cannabis
      • CBD-Hemp
      • Technology
    • Advisory
      • Turn Around & Transformation
      • Board Member Recruitment
      • PPMs, CIMs, Executive Summaries and Pitch Decks
      • Financial Modeling and Capital Planning
      • Product Commercialization
  • Access to Capital
    • Debt Funding
      • MTN
    • M&A
  • Canna-Hemp Debt Fund
    • Cannabis Capital Markets
    • The Fund
  • Insights
    • Blog33
    • The Edge Newsletters
    • News & Events
    • Tracking Smart Money
Phamaceuticals

Follow the Smart Money in Pharma 2020

August 6, 2020
Search
Recent Posts
Press Release: President Trump Signals Marijuana Rescheduling Decision Imminent
August 14, 2025
At long last, the Minnesota Adult-Use Cannabis Market Begins
July 10, 2025
The cannabis industry has been on fire in 2024
February 25, 2025
Categories
  • Blog
  • Highway Edge: Biotech
  • Highway Edge: Cannabis
  • Highway Edge: Pharma
  • Highway Edge: Technology
  • News
Highway 33 Capital Advisory Logo

Buy side. Sell side. Your side.

Get in Touch
MIAMI - DENVER - DETROIT - SAN FRANCISCOEmail: info@highway33.comPhone: +1 (800) 684-9238
Subscribe


    I have read and agree to the terms & conditions

    Highway 33 Capital Advisory © 2025. All rights reserved.

    • Privacy Policy
    • SEC FINRA Disclaimer